In an effort to identify possible risk factors for stroke in Sickle Ce
ll Anemia (Hb SS), we analyzed the distribution of alpha-globin gene d
eletions in a group of Hb SS patients with and without stroke. The gro
up with stroke consisted of 44 patients, (27 male, 17 female) with a m
ean of 7.5 years at time of stroke. The control group (non-stroke) had
256 Hb SS patients (126 male, 130 female) with a mean age of 7.7 year
s. There were 9 patients with heterozygous alpha-thalassemia in the st
roke group (20.5%). In the control group, there were 93 patients with
heterozygous alpha-thalassemia and 5 with homozygous alpha-thalassemia
. The incidence of alpha-thalassemia in Hb SS patients without stroke
(38%) was comparable to that reported for the African-American populat
ion in general. The incidence in the stroke population (20.5%) was sig
nificantly lower (P = 0.02) These results indicate that alpha-thalasse
mia is associated with a lower risk of stroke in Hb SS. This observati
on should be confirmed in studies involving larger numbers of patients
. Possible protective effects of alpha-thalassemia are unknown but may
be related to decreased hemolysis and more favorable theologic proper
ties of red blood cells. (C) 1994 Wiley-Liss, Inc.